Tibet Weixinkang Pharmaceutical (603676.SH) obtained the drug registration certificate for Compound Amino Acid Injection (18AA-).

Xizang Weixinkang Pharmaceutical (603676.SH) announced that its wholly-owned subsidiary Inner Mongolia Baiyi Pharmaceutical Co., Ltd. ("Baiyi Pharmaceutical") recently received the drug registration certificate for Compound Amino Acid Injection (18AA-) issued by the National Medical Products Administration. Compound Amino Acid Injection (18AA-) is an amino acid supplement for adults, used for amino acid supplementation in cases of hypoproteinemia, malnutrition, and before and after surgery.